PDCD1 and neoplasm: Besides the conventional extrinsic role of the PD-1/PD-L1 axis in inhibiting the immune system—exploited by neoplastic cells, contributing to acquired resistance—recent studies have revealed a tumor-intrinsic role of PD-1 and PD-L1 that might further affect therapy response [117].